Annual Revenue
$182.95 M
+$165.51 M+948.62%
December 31, 2024
Summary
- As of February 28, 2025, TARS annual revenue is $182.95 million, with the most recent change of +$165.51 million (+948.62%) on December 31, 2024.
- During the last 3 years, TARS annual revenue has risen by +$125.93 million (+220.82%).
- TARS annual revenue is now at all-time high.
Performance
TARS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
December 31, 2024
Summary
- TARS quarterly revenue is not available.
Performance
TARS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
December 31, 2024
Summary
- TARS TTM revenue is not available.
Performance
TARS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TARS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +948.6% | - | - |
| 3 y3 years | +220.8% | - | - |
| 5 y5 years | - | - | - |
TARS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +948.6% | ||||
| 5 y | 5-year | at high | +948.6% | ||||
| alltime | all time | at high | +948.6% |
Tarsus Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $182.95 M(+948.6%) | - | - |
| Sep 2024 | - | $48.12 M(+17.9%) | $129.62 M(+55.5%) |
| Jun 2024 | - | $40.81 M(+47.8%) | $83.37 M(+95.9%) |
| Mar 2024 | - | $27.61 M(+111.2%) | $42.56 M(+143.9%) |
| Dec 2023 | $17.45 M(-32.4%) | $13.08 M(+598.9%) | $17.45 M(+21.4%) |
| Sep 2023 | - | $1.87 M(-25.2%) | $14.37 M(-48.3%) |
| Mar 2023 | - | $2.50 M(-75.0%) | $27.78 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $25.82 M(-54.7%) | $10.00 M(-34.5%) | $25.82 M(+48.4%) |
| Jun 2022 | - | $15.28 M(+2734.3%) | $17.39 M(-27.9%) |
| Mar 2022 | - | $539.00 K(+59.5%) | $24.13 M(-57.7%) |
| Dec 2021 | $57.03 M | $338.00 K(-72.7%) | $57.03 M(+0.6%) |
| Sep 2021 | - | $1.24 M(-94.4%) | $56.69 M(+2.2%) |
| Jun 2021 | - | $22.02 M(-34.1%) | $55.45 M(+65.9%) |
| Mar 2021 | - | $33.43 M | $33.43 M |
FAQ
- What is Tarsus Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual revenue year-on-year change?
- What is the all time high quarterly revenue for Tarsus Pharmaceuticals?
- What is the all time high TTM revenue for Tarsus Pharmaceuticals?
What is Tarsus Pharmaceuticals annual revenue?
The current annual revenue of TARS is $182.95 M
What is the all time high annual revenue for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual revenue is $182.95 M
What is Tarsus Pharmaceuticals annual revenue year-on-year change?
Over the past year, TARS annual revenue has changed by +$165.51 M (+948.62%)
What is the all time high quarterly revenue for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly revenue is $48.12 M
What is the all time high TTM revenue for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high TTM revenue is $129.62 M